L. Rocha et al., APOLIPOPROTEIN-E GENOTYPE OF A PORTUGUESE CONTROL POPULATION AND ALZHEIMERS-DISEASE PATIENTS, European journal of neurology, 4(5), 1997, pp. 448-452
The present work first describes the frequency of APOE alleles and gen
otypes in Portuguese populations in relation to AD pathology. We genot
yped a group of late onset sporadic AD cases, their pairwise controls
and a larger group of randomly selected individuals, to assess the dis
tribution pattern of APOE alleles in the Portuguese population, APOE e
psilon 4 relative frequency may significantly vary among different pop
ulations-a fact which should be taken into consideration for the corre
ct evaluation of the cossegregation of this allele with AD pathology,
We observed a frequency of 0.087 +/- 0.029 of the APOE epsilon 4 and 0
.043 +/- 0.021 of the APOE epsilon 2 allele in the Portuguese random p
opulation which as expected showed a marked prevalence of the APOE eps
ilon 3 form (0.870 +/- 0.035). In the AD patients the APOE epsilon 4 a
llele frequency was significantly higher (0.360 +/- 0.081) than in the
controls (chi(2) = 31.000, p < 0.00001, df = 2). Consistently APOE ep
silon 3 allele frequency (0.640 +/- 0.081) was significantly lower tha
n in the controls while APOE epsilon 2 was absent in the studied AD po
pulation. Taken together our results demonstrate that the Portuguese p
opulation is characterized by a relatively low frequency of the APOE e
psilon 4 allele, in good agreement with previous observations of a gra
dient of epsilon 4 allele frequency in Europe, decreasing from North t
o South. Several lines of evidence point at APOE epsilon e4 allele as
a major genetic susceptibility factor in AD. The APOE epsilon 4 allele
was significantly higher [odds ratio (OR) = 5.93, 95% CI 3.55-9.91] i
n the Portuguese AD patients than in the random non-demented populatio
n, The genotype analysis of the Portuguese AD patients here described
reveals a marked, increased frequency of epsilon 4 homo- and heterozyg
ous individuals consistent with an APOE epsilon 4 zigosity effect as a
further genetic trait predisposing to AD development.